{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:41:55Z","timestamp":1740120115106,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand","award":["MURA 2021\/286"],"award-info":[{"award-number":["MURA 2021\/286"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s12185-022-03456-z","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T17:39:51Z","timestamp":1663954791000},"page":"293-306","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Iliopsoas haemorrhage complicated by femoral neuropathy in patients with haemophilia: a case series report"],"prefix":"10.1007","volume":"117","author":[{"given":"Monratta","family":"Panuwannakorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tachit","family":"Jiravichitchai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surapong","family":"Lertthammakiat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suphaneewan","family":"Jaovisidha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nongnuch","family":"Sirachainan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1230-1591","authenticated-orcid":false,"given":"Ampaiwan","family":"Chuansumrit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"3456_CR1","first-page":"3","volume-title":"Haemophilia: treatment and prevention","author":"A Chuansumrit","year":"2017","unstructured":"Chuansumrit A. Haemophilia: treatment and prevention. Bangkok: Chaicharoen; 2017. p. 3\u20136."},{"key":"3456_CR2","unstructured":"National Health Security Office (2021) Disease management information system"},{"issue":"10","key":"3456_CR3","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1111\/jth.15424","volume":"19","author":"S Hassan","year":"2021","unstructured":"Hassan S, van Balen EC, Smit C, Mauser-Bunschoten EP, van Vulpen LFD, et al. Health and treatment outcomes of patients with hemophilia in the Netherlands 1972\u20132019. J Throm Haemost. 2021;19(10):2394\u2013406.","journal-title":"J Throm Haemost"},{"issue":"Suppl 2","key":"3456_CR4","first-page":"92","volume":"76","author":"A Chuansumrit","year":"1993","unstructured":"Chuansumrit A, Isarangkura P, Hathirat P, Chiewsilp P, Kittikol J. Care of Thai hemophilia patients from 1969 to 1991. J Med Assoc Thai. 1993;76(Suppl 2):92\u2013102.","journal-title":"J Med Assoc Thai"},{"key":"3456_CR5","first-page":"28","volume-title":"Recent advances in rehabilitation in haemophilia","author":"P Kleijn","year":"1999","unstructured":"Kleijn P. Physiotherapy management of iliopsoas haemorrhages. In: Heijnen L, editor. Recent advances in rehabilitation in haemophilia. East Sussex: Medical Educational Network; 1999. p. 28\u201338."},{"key":"3456_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/9780470986929","volume-title":"The haemophilic joints. New perspectives","author":"EC Rodriguez-Merchan","year":"2003","unstructured":"Rodriguez-Merchan EC. Orthopedic surgery for persons with haemophilia: general principles. In: Rodriguez-Merchan EC, editor. The haemophilic joints. New perspectives. Oxford: Blackwell Publishing; 2003. p. 8\u20139."},{"key":"3456_CR7","first-page":"117","volume-title":"Physiotherapy management of haemophilia","author":"EC Rodriguez-Merchan","year":"2000","unstructured":"Rodriguez-Merchan EC. Orthopedic surgery in haemophilia. In: Buzzard B, Beeton K, editors. Physiotherapy management of haemophilia. Oxford: Blackwell Science; 2000. p. 117\u20138."},{"key":"3456_CR8","first-page":"177","volume-title":"The haemophilic joints. New perspectives. Massachusetts","author":"J York","year":"2003","unstructured":"York J. Neurological lesions following musculoskeletal bleeding in haemophilia. In: Rodriguez-Merchan EC, editor. The haemophilic joints. New perspectives. Massachusetts. Oxford: Blackwell Publishing; 2003. p. 177."},{"key":"3456_CR9","first-page":"167","volume":"51","author":"SK Saraf","year":"2003","unstructured":"Saraf SK, Singh OP, Singh VP. Peripheral nerve complications in hemophilia. J Assoc Physicians India. 2003;51:167\u20139.","journal-title":"J Assoc Physicians India"},{"issue":"5","key":"3456_CR10","first-page":"406","volume":"33","author":"LX Chen","year":"2012","unstructured":"Chen LX, Hua BL, Liu Y, Luo L, Zhang JP, Zhang HY, Zhao YQ. Clinical characteristics and rehabilitation treatment of iliopsoas hemorrage in 41 patients with hemophilia. Zhonghua Xue Ye Xue Za Zhi. 2012;33(5):406\u20138.","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"8","key":"3456_CR11","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1080\/17474086.2020.1787146","volume":"13","author":"EC Rodriguez-Merchan","year":"2020","unstructured":"Rodriguez-Merchan EC, De la Corte-Rodriguez H. Iliopsoas hematomas in people with hemophilia: diagnosis and treatment. Expert Rev Hematol. 2020;13(8):803\u20139.","journal-title":"Expert Rev Hematol"},{"issue":"6","key":"3456_CR12","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1046\/j.1351-8216.2003.00822.x","volume":"9","author":"AA Ashrani","year":"2003","unstructured":"Ashrani AA, Osip J, Christie B, Key NS. Iliopsoas haemorrhage in patients with bleeding disorders\u2013experience from one centre. Haemophilia. 2003;9(6):721\u20136.","journal-title":"Haemophilia"},{"key":"3456_CR13","volume-title":"Daniels and Worthingham\u2019s muscle testing: techniques of manual examination","author":"HJ Hislop","year":"1995","unstructured":"Hislop HJ, Montgomery J. Daniels and Worthingham\u2019s muscle testing: techniques of manual examination. 6th ed. Philadelphia: W.B. Saunders Company; 1995.","edition":"6"},{"issue":"1","key":"3456_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/hae.14194","volume":"27","author":"A Chuansumrit","year":"2021","unstructured":"Chuansumrit A, Sirachainan N, Natesirinilkul R, Srikala K, Masaya-Anon N, Haemophilia Inhibitor Study Group. Real-world evidence on health resource use among patients with haemophilia and inhibitor exhibiting severe bleeding episodes. Haemophilia. 2021;27(1):69\u201380.","journal-title":"Haemophilia"},{"issue":"5","key":"3456_CR15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1365-2516.2005.01123.x","volume":"11","author":"C Balkan","year":"2005","unstructured":"Balkan C, Kavakli K, Karapinar D. Iliopsoas haemorrhage in patients with haemophilia: results from one centre. Haemophilia. 2005;11(5):463\u20137.","journal-title":"Haemophilia"},{"issue":"1","key":"3456_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jelekin.2003.09.009","volume":"14","author":"DM Rempel","year":"2004","unstructured":"Rempel DM, Diao E. Entrapment neuropathies: pathophysiology and pathogenesis. J Electromyogr Kinesiol. 2004;14(1):71\u20135.","journal-title":"J Electromyogr Kinesiol"},{"issue":"Suppl 6","key":"3456_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hae.14046","volume":"26","author":"A Srivastava","year":"2020","unstructured":"Srivastava A, Santagostino E, Dougall A, Kitchen S, Sutherland S, Pipe SW, et al. WFH guidelines for the management of hemophilia. Haemophilia. 2020;26(Suppl 6):1\u2013158. https:\/\/doi.org\/10.1111\/hae.14046.","journal-title":"Haemophilia"},{"issue":"4","key":"3456_CR18","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/bjh.15053","volume":"180","author":"RCR Ljung","year":"2018","unstructured":"Ljung RCR. How I manage patients with inherited haemophilia A and B and factor inhibitors. Br J Haematol. 2018;180(4):501\u201310.","journal-title":"Br J Haematol"},{"issue":"1","key":"3456_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1055\/s-2003-37941","volume":"29","author":"G Mariani","year":"2003","unstructured":"Mariani G, Siragusa S, Kroner BL. Immune tolerance induction in hemophilia A: a review. Semin Thromb Hemost. 2003;29(1):69\u201376.","journal-title":"Semin Thromb Hemost"},{"issue":"21","key":"3456_CR20","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1056\/NEJMoa1511769","volume":"374","author":"M Shima","year":"2016","unstructured":"Shima M, Hanabusa H, Taki M, Matsushita T, Sato T, Fukutake K, et al. Factor VIII-mimetic function of humanized bispecific antibody in hemophilia A. N Engl J Med. 2016;374(21):2044\u201353.","journal-title":"N Engl J Med"},{"issue":"9","key":"3456_CR21","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1703068","volume":"377","author":"J Oldenburg","year":"2017","unstructured":"Oldenburg J, Mahlangu JN, Kim B, Schmitt C, Callaghan MU, Young G, et al. Emicizumab prophylaxis in hemophilia A with inhibitors. N Engl J Med. 2017;377(9):809\u201318.","journal-title":"N Engl J Med"},{"issue":"24","key":"3456_CR22","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1182\/blood.2019001869","volume":"134","author":"G Young","year":"2019","unstructured":"Young G, Liesner R, Chang T, Sidonio R, Oldenburg J, Jim\u00e9nez-Yuste V, et al. A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors. Blood. 2019;134(24):2127\u201338.","journal-title":"Blood"},{"issue":"2","key":"3456_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/bjh.12091","volume":"160","author":"PW Collins","year":"2013","unstructured":"Collins PW, Chalmers E, Hart DP, Liesner R, Rangarajan S, Talks K, et al. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization. Br J Haematol. 2013;160(2):153\u201370.","journal-title":"Br J Haematol"},{"issue":"5","key":"3456_CR24","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1182\/blood-2021-147630","volume":"138","author":"A Chuansumrit","year":"2021","unstructured":"Chuansumrit A, Sirachainan N, Jaovisidha S, Jiravichitchai T, Kadegasem P, Kempka K, et al. Effectiveness of monthly low-dose emicizumab prophylaxis without 4-week loading doses among patients with hemophilia A with and without inhibitor: a case series report. Blood. 2021;138(5):2116\u20137.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03456-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-022-03456-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03456-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T17:00:13Z","timestamp":1675184413000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-022-03456-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["3456"],"URL":"https:\/\/doi.org\/10.1007\/s12185-022-03456-z","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"assertion":[{"value":"29 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.C. acts advisory board of Novo Nordisk and has received honoraria from Novo Nordisk, Grifols, Takeda and Roche while the other authors state that they have no interests which might be perceived as posing a conflict or bias.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}